Related by context. All words. (Click for frequent words.) 78 Homspera TM 76 derivatives Radilex TM 73 Viprovex R 70 kidney urologic 70 therapeutic monoclonal antibodies 70 oncolytic viruses 69 delafloxacin 69 FOLOTYN ® 69 gastro intestinal inflammation 69 investigational monoclonal antibody 68 small molecule defensin 68 NS#/#A protease 68 anticoagulant reversing agent 68 NEUGENE 68 CYT# potent vascular disrupting 68 Solazed TM 68 therapeutic monoclonal antibody 68 Tarvacin TM 67 selective androgen receptor modulators 67 Alfacell proprietary ribonuclease 67 humanized monoclonal antibodies 67 myelofibrosis polycythemia vera 67 engineered RAP peptides 67 Nanobody ® 67 targeted radiotherapeutic 67 stable nucleic acid 67 Personalized Immunotherapy 67 KL4 Surfactant 67 Immunotherapeutic 67 sorafenib tablets 67 JAK2 inhibitor 67 vascular disrupting agents 66 Locked Nucleic Acid LNA 66 adrenergic regulation 66 Aganocide ® 66 NovaBay Aganocide compounds 66 acne impetigo 66 tiapamil 66 oral Janus kinase 66 HuCAL GOLD R 66 THR beta agonist 66 novel VDA molecule 66 reverse vaccinology 66 recombinant subunit vaccine 66 Aviptadil 66 virosome 66 anti infective treatments 66 CysDisplay R 66 systemic fungal infections 66 immunomodulatory properties 66 MTP inhibitor 66 erlotinib Tarceva ® 66 Xcytrin R 66 oral prodrug 66 histone deacetylase HDAC 66 small molecule activators 66 anticancer therapeutics 65 AEG# 65 Davunetide 65 Deforolimus 65 Prodarsan R 65 mertansine 65 myeloproliferative disorders 65 p# inhibitor 65 novel immunomodulatory 65 OTCBB PWRM.OB 65 platform HDL Mimetic 65 Tß4 65 anti aging glycopeptides 65 PEGylated 65 ImmuneRegen BioSciences Inc. 65 Squalamine 65 Curaxins 65 Stapled Peptide 65 proteasome inhibitor 65 OMP #M# 65 commercializing anti infective 65 candidates Azedra TM 65 theranostic 65 Ibis T# TM 65 INCB# [003] 65 Zemiva TM 65 Safinamide 65 biologic therapeutics 65 siRNA therapeutic 65 nanoviricides 65 antagomirs 65 CD# CEA 65 samarium Sm 65 thiazolides 65 immunotherapeutics 64 Onconase 64 Curaxin 64 novel antibody therapeutics 64 Factor VIIa 64 Onalta 64 rxRNA 64 candidates Azedra 64 Tezampanel 64 Oracea TM 64 ELADUR ™ 64 infectious diseases autoimmune diseases 64 Hsp# Inhibitor 64 fibrin derived 64 orally administered inhibitor 64 Onalta TM 64 IMiDs R 64 humanized monoclonal 64 huC# DM4 64 romazarit 64 Nanobody 64 MAGE A3 ASCI 64 CTAP# Capsules 64 siRNA compounds 64 Azedra 64 treat chronic sinusitis 64 Sudhir Agrawal D.Phil 64 vitreoretinal disorders 64 RNAi therapeutic targeting 64 JAK inhibitor 64 Friedreich Ataxia FRDA 64 Myocet 64 Xanafide 64 pan HDAC inhibitor 64 itraconazole Sporanox 64 pralatrexate injection folate analogue 64 metastatic neuroendocrine tumors 64 antifungal agent 64 Solazed ™ 64 OMNARIS HFA 64 novel peptide 64 vinca alkaloid 64 anionic backbone 64 ALN PCS 64 NPC 1C 64 MKC# MT 64 NEUGENE R 64 proliferative diseases 64 M2 subunit 64 Cerashield 64 TPI ASM8 64 Ridaforolimus 64 PROSTASCINT R 64 immunotherapeutic approaches 64 IMiDs ® 64 biodefense pathogens 64 ALN TTR 64 antiangiogenesis therapies 64 Vidaza ® 64 A3 adenosine receptor 64 Prodarsan ® 64 DiLA2 64 CBLC# 64 immunotoxins 64 liposomal delivery 64 CD# monoclonal antibody 64 TNF Tumor Necrosis Factor 64 Locked Nucleic Acid 64 MCSP respectively 64 uricase 63 oral proteasome inhibitor 63 novel immunotherapies 63 Preclinical Study 63 Aurexis R 63 R Saizen R 63 BCR ABL inhibitors 63 PORxin TM platforms 63 OTCBB PYTO 63 selective kinase inhibitor 63 Ceflatonin 63 bexarotene 63 preclinically 63 RhuDex ® 63 antibiofilm 63 antisense inhibitors 63 HepDirect prodrug 63 Spiegelmers R 63 BAL# [001] 63 MT#/MEDI-# 63 Angiocept 63 neovascular diseases 63 Archexin 63 CCR9 antagonist 63 oncolytic virus therapies 63 Haptoglobin 63 Platelet Derived Growth 63 TLR antagonists 63 dermatological disorders 63 oral transdermal 63 Sapacitabine 63 Reports Preclinical Data 63 synthetic cannabinoid compounds 63 selective inhibition 63 activity dependent neuroprotective 63 Homspera 63 Anticalins 63 SARMs 63 GRN# 63 SNALP technology 63 Panzem 63 Thiovir 63 ocular formulation 63 investigational humanized monoclonal antibody 63 Initiates Clinical Trial 63 CEQ# 63 non alcoholic steatohepatitis 63 epithelial tumors 63 immuno inflammatory diseases 63 protein kinase inhibitor 63 HCV NS3 protease 63 Nanobodies ® 63 relapsed leukemia 63 immatics 63 human antibody therapeutics 63 HuCAL GOLD ® 63 OXIGON TM 63 small molecule activator 63 monoclonal antibody therapeutics 63 HCV protease inhibitors 63 Factor VEGF 63 proprietary PEGylation 63 bevacizumab Avastin ® 63 MVA BN R 63 small molecule agonists 63 NYSE Amex PBTH 63 anticancer compounds 63 targeted antifolate 63 NB S# strontium malonate 63 mda 7 63 vivo validation 63 lipid particles 63 Vaxfectin TM 63 coronary stent merged 63 NS5b 63 TÎ ² 4 63 mucosal vaccines 63 Eraxis 63 Phase #b/#a clinical 63 Aganocide 63 humanised monoclonal antibody 63 mimetics 63 CollaFix TM 63 TRANSDUR ™ 63 TELINTRA 63 lexidronam injection 63 humanized anti 63 cancer immunotherapies 63 trastuzumab Herceptin R 63 Litx 63 platinum chemotherapeutic 63 ALN TTR# 63 molecular chaperone regulation 63 rxRNA compounds 63 TKB# 63 pathophysiological effects 63 PROLOR Biotech Inc. 63 Zalypsis 63 Ceflatonin R 63 P#X# antagonist 63 recurrent metastatic ovarian cancer 63 sulfonylhydrazine class 63 IAP inhibitors 63 Cotara ® 63 Tesetaxel 63 protein ADNP 63 Spiegelmers 63 antisense drug 63 polymerase inhibitors 63 hereditary emphysema 63 cyclophilin inhibitors 63 ACV1 63 molecular biomarkers 63 OTCBB HXBM developer 63 radezolid 63 cMET 63 Radiation Therapy SIRT 63 NASH Huntington 63 Initiates Enrollment 62 hemorrhagic fever viruses 62 essential thrombocythemia ET 62 isoform selective 62 Cx# [002] 62 JAK inhibitors 62 MEK inhibitors 62 IMiDs ® compound 62 HQK 62 product platforms AZX# 62 metaglidasen 62 lead molecular radiotherapeutic 62 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 62 NNR Therapeutics 62 vivo fluorescence imaging 62 ADAMTS# 62 TRANSDUR ® 62 Radilex 62 accumulate preferentially 62 Bioral ® 62 toenail onychomycosis 62 Logical Therapeutics 62 cetuximab Erbitux R 62 virotherapy 62 Omacetaxine 62 methylation markers 62 novel antiviral therapeutics 62 BRAF kinase 62 SinuNase ™ 62 acetonide FA 62 Myolimus 62 HepDirect R 62 histone deacetylase inhibitor 62 SAR# [002] 62 DOS# 62 targeting CD# 62 Liprotamase 62 Romidepsin 62 Carfilzomib 62 GVAX ® 62 purinergic receptors P#X# 62 AzaSite Xtra 62 enzyme cofactor 62 AtuRNAi 62 Therapeutic Competitors Companies 62 invasive candidiasis 62 dihydrochloride Tablets 62 QUADRAMET R 62 Palifosfamide 62 PEG SN# 62 Ribavirin causes 62 investigational pan BCR 62 protein kinase inhibitors 62 NeutroPhase TM 62 OncoVex 62 monoclonal anti 62 Shigatoxin producing E. coli 62 NXL# 62 RenaZorb TM 62 thalidomide Thalomid 62 JAK2 kinase 62 SIRT1 activators 62 signal transduction inhibitors 62 taxane derivative 62 Excellarate TM 62 diarrhea predominant irritable 62 butyrylcholinesterase 62 MAbs targeting 62 AVI NEUGENE 62 alkylating 62 TLR9 agonist 62 vinca alkaloids 62 topically applied SEPA 62 Cardium Therapeutics TM 62 Human cl 62 histone deacetylase HDAC inhibitors 62 Aganocide R 62 Sphingomab 62 either acutely decompensated 62 candidate XP# 62 catalytic antioxidant compounds 62 HGS ETR1 mapatumumab 62 HSP# inhibitors 62 imatinib Gleevec ® 62 vapreotide acetate 62 commercialize Aganocides 62 familial amyloidotic polyneuropathy FAP 62 peptidic 62 attach auristatin 62 triggers apoptosis programmed 62 Protexia R 62 tigecycline 62 Amplimexon 62 HuCAL PLATINUM ® CysDisplay 62 Copegus R 62 Epeius Biotechnologies Corporation 62 equine osteoarthritis 62 PGL# 62 Colaris Colaris AP 62 Therapeutic antibodies 62 afamelanotide 62 anti CD# antibodies 62 immuno therapeutic 62 PNP inhibitor 62 potent inhibitors 62 Combivir Kivexa 62 KL4 surfactant 62 SPL# Gel vaginal microbicide 62 diagnostic biomarkers 62 Viral Immunotherapy platform 62 aerosolized AAT 62 fusion enhancers 62 Quark Biotech Inc. 62 blood serum biomarkers 62 deCODE chemistry 62 dSLIM 62 Navelbine ® 62 Alzheimer disease cognitive impairment 62 IAP inhibitor 62 Radezolid 62 Adnectin 62 IMiDs 62 Cytomegalovirus CMV 62 POTELLIGENT ® 62 GRNOPC1 contains 62 Initiates Phase II 62 telomerase activators 62 GRNCM1 62 HCV protease 62 JAK1 62 HuLuc# 62 GVAX cancer 62 Angiolix 62 antiviral compounds 62 Familial Adenomatous Polyposis FAP 62 Ampligen ® 62 RNA interference RNAi therapeutics 62 small molecule thrombopoietin 62 immunomodulatory 62 MKC# MKC# PP 62 nucleoside analogues 62 CB2 receptor 62 adenosine A2A 62 SinuNase TM 62 Tr DNA 62 recombinant antibodies 62 metabolomic profiling 62 Ibis T# 62 Brussels THR 62 Selzentry Celsentri 62 HydroFix TM 62 Nasdaq CGEN 62 Transdrug ® nanoparticle 62 INS# [001] 62 G Protein Coupled 62 DURECT proprietary 62 cobiprostone 62 radiation sensitizer 62 Potelligent 62 antimicrobial compounds 62 potent antiproliferative 62 transfection reagents 62 renin inhibition promising 62 HDAC inhibition 62 pharmacogenetic test 62 Bucindolol 62 adult mesenchymal stem 62 hyaluronidase enzyme 62 monoclonal antibody conjugated 62 diagnostic biomarker 62 PORxin TM 62 Cathepsin S 62 histone deacetylase HDAC inhibitor 62 Voreloxin 62 HuCNS SC ® 62 Tarvacin 62 protein tyrosine phosphatase 1B 62 iobenguane 62 Regenerative Cells 62 oral JAK#/JAK# inhibitor 62 Elvitegravir 62 treat refractory angina 62 Inotek Pharmaceuticals Corporation 62 personalized cellular immunotherapy 62 ZFN TM 62 IMA# 62 PDE4 inhibitor 62 LHRH antagonists 62 IL# PE#QQR 62 RNA antagonist 62 candidate CRLX# 61 detection reagents 61 ATL# [002] 61 Completes Patient Enrollment 61 Inc. AMEX YMI 61 novel anticancer 61 CD3 monoclonal antibody 61 OvaRex R 61 polyneuropathy HIV DSP 61 miRview meso 61 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 61 Panzem NCD 61 Antigenics QS 61 Guanilib 61 Protein Kinase C 61 TACI Ig 61 Akt inhibitor 61 HTS assay 61 depsipeptide 61 trastuzumab DM1 T DM1 61 Oral NKTR 61 DermaVir 61 INxin TM 61 orally administered pharmacological chaperones 61 PSN# [001] 61 MDRNA proprietary 61 immunotherapeutic 61 LymphoStat B TM 61 novel peptides 61 MyVax R 61 oral antiviral 61 antigen sparing 61 TLR8 agonist 61 systemically administered 61 TCAD therapy 61 AQD class 61 delta isoform 61 Symadex 61 OTCBB ADXS 61 sodium glucose cotransporter 61 preclinical efficacy 61 NASDAQ SNTA 61 ATRA IV 61 oral dual endothelin 61 Respiratory Syncytial Virus RSV 61 OTCBB IMUC 61 Tyrima 61 human rhinovirus HRV 61 BioVant 61 4SC AG ISIN DE# 61 Cannabinor 61 Epstein Barr Virus EBV 61 ZFP Therapeutic 61 Syndax Pharmaceuticals Inc. 61 intranasal formulation 61 NuMimetic TM 61 Epidermal Growth Factor Receptor 61 Interferon alpha 61 non nucleoside inhibitor 61 TG# [003] 61 AVE# 61 MEK inhibitor 61 Darapladib 61 next generation URAT1 61 rusalatide acetate 61 Anidulafungin 61 neuropathic pain spasticity 61 Darinaparsin 61 beta lactams 61 tests miRview TM 61 drugable targets 61 Kuvan sapropterin dihydrochloride 61 Azixa 61 acadesine 61 delivers fluocinolone acetonide FA 61 Granulocyte Colony Stimulating Factor 61 antiangiogenesis 61 demonstrated antitumor activity 61 Phase IIb clinical trials 61 novel anti infective 61 oncolytic 61 synthetic siRNA 61 using Innocoll proprietary 61 cartilage regeneration 61 ArQule Kinase Inhibitor Platform 61 Campath ® 61 theranostics 61 HCV polymerase inhibitors 61 Vidaza R 61 siRNA delivery 61 Nasdaq PARD 61 SMARTICLES ® 61 adrenal steroid hormones 61 chemically modified tetracyclines 61 immunoregulation 61 PDX pralatrexate 61 acyclovir Lauriad R 61 NurOwn 61 fluoroquinolone antibiotic 61 GERD migraine headaches 61 Cytotoxic 61 tubulin binding 61 BRAF inhibitors 61 ribonucleotide reductase clinically validated 61 Sphingomab TM 61 VDAs 61 metastatic colorectal 61 Methylnaltrexone 61 Arimoclomol 61 IR BioSciences Holdings 61 Maribavir 61 virus HCV protease inhibitor 61 Teplizumab 61 Smac mimetics 61 velafermin 61 DAS# [001] 61 2 methoxyestradiol 61 VeriStrat 61 CR# vcMMAE 61 epigenetic therapies 61 lipid nanoparticle 61 motexafin gadolinium Injection 61 liposomal formulation 61 chimeric monoclonal antibody 61 Aflibercept 61 Alexza Staccato 61 anti amnesic 61 Disease IBD 61 NEUGENE antisense 61 XP #L 61 Microplasmin 61 Fludara ® 61 PLX cells 61 CG# [003] 61 Annamycin 61 refractory chronic lymphocytic 61 ketolide antibiotic 61 Receptos 61 Prochymal TM 61 YONDELIS 61 cytotoxin 61 proteasome inhibitors 61 IV Busulfex 61 Veronate R 61 Evoltra ® 61 hypoxia selective 61 PEGylated Fab fragment 61 skeletal muscle weakness 61 HuMax EGFr 61 Dicer Substrate Technology 61 Nasdaq HALO 61 PrevOnco 61 ADCC enhanced 61 Aptamer 61 nucleoside analog 61 RECOTHROM ® 61 AKIP ™ 61 PEGylation technology 61 neuroendocrine cancers 61 Tobira Therapeutics 61 Aurora Kinase 61 Panzem R NCD 61 Fc fusion protein 61 molecular imaging radiopharmaceutical 61 lung pancreatic 61 Scancell 61 HuCAL R 61 methylnaltrexone bromide 61 ulimorelin 61 InfaCare Pharmaceutical Corporation 61 Atripla combines 61 SAR# [004] 61 anti secretory 61 human C1 inhibitor 61 fluoroquinolone class 61 recombinant polyclonal antibodies 61 CINtec R 61 superparamagnetic iron oxide nanoparticles 61 CB2 receptor selective 61 ALK inhibitors 61 patented Bioral 61 Multimeric 61 Adenoscan R 61 immuno modulatory 61 Dalbavancin 61 transthyretin TTR mediated amyloidosis 61 recombinant vaccines 61 BRAF inhibitor 61 Fleximer R 61 Enzastaurin 61 Parkinson disease levodopa induced 61 VitiGam 61 Presents Preclinical Data 61 Transfection Reagent 61 XmAb ™ 61 CollaFix ™ 61 Tarmogen 61 Elesclomol 61 cleavable linker 61 Zolinza 61 Zysolin TM 61 kinase inhibition 61 vaccines oncolytic virus 61 Oragens TM 61 PKC# 61 candidate deforolimus 61 potent anticancer 61 phase Ib clinical 61 thymalfasin 61 XL# anticancer compounds 61 treat male hypogonadism 61 identify protein biomarkers 61 ANG# 61 antibody MAb 61 autoimmune inflammatory 61 Dacetuzumab 61 enhance ApoA 61 siRNA binds 61 Nasdaq IDIX biopharmaceutical 61 peptidic compound 61 Acute Radiation Syndrome ARS 61 Morria Biopharmaceuticals Plc 61 PRTX 61 antibody fragment 61 NasdaqGM SPPI 61 thymosin beta 4 61 neuroprotective properties 61 Selective Electrochemical Tumor Ablation 61 mAbs 61 pentadentate logo R 61 monoclonal 61 Nautilus Biotech 61 using VIAdel TM 61 BioSilicon TM 61 systemic RNAi therapeutic 61 intravesical instillation 61 Nasdaq RDEA 61 Provectus Pharmaceuticals specializes 61 Janus kinase 61 coagulation factor VIIa 61 Gel repository corticotropin injection 61 Cetrorelix 61 drug ISA# 61 Nasdaq HALO biopharmaceutical 61 thymidylate synthase 61 anticancer therapy 61 receptor tyrosine kinase inhibitor 61 sodium thiosulfate STS 61 Adult Stem Cell Therapy 61 sirtuin therapeutics 61 immune modulatory 61 Tarvacin Anti Viral 61 ALTROPANE R 61 Rhucin ® recombinant 60 ddRNAi 60 meropenem 60 neuronal nicotinic receptors NNRs 60 Pruvel TM 60 Vascular Endothelial Growth 60 Myrexis Inc. 60 herpetic keratitis 60 Endotis 60 novel orally bioavailable 60 phase IIb clinical 60 prokinetic agent 60 EP #R 60 IL# PE 60 immunologic diseases 60 vascular disrupting agent 60 Pertuzumab 60 Hyaluronan 60 diagnostic molecular imaging 60 GSK# [002] 60 compound AEZS 60 hematological cancers 60 2 inhibitor CYT# 60 INSPIRE Trial Phase III 60 OMP #R# 60 thetreatment 60 Prednisporin 60 nitric oxide donating 60 gastrointestinal disorders ATI 60 Factor Receptor 60 GMX# 60 induced mucositis 60 gastrointestinal mucositis 60 Anticalins R 60 ENMD # 60 K ras mutations 60 Restoraderm R 60 MitoQ 60 Dapagliflozin 60 Intermezzo ® zolpidem tartrate 60 intranasal delivery 60 antisense drugs 60 Alocrest 60 NP2 Enkephalin 60 TLK# 60 histone deacetylase inhibitors 60 Supernus Pharmaceuticals 60 Interferons 60 pharmacodynamic properties 60 Civacir 60 factor VIIa 60 sapropterin dihydrochloride Tablets 60 Elotuzumab 60 LNP formulations 60 exon skipping 60 favorable pharmacokinetic profile 60 bioactive compound 60 Psoraxine R 60 immunotherapeutic vaccine 60 prostate cancer antigen prostatic 60 EndoTAG TM 60 Macrolide 60 Bendavia 60 Presents Preclinical 60 blood coagulation disorders 60 Clolar ® 60 Mipomersen 60 oral ghrelin agonist 60 Corgentin 60 mGluR2 NAM 60 Valortim TM 60 Hemopurifier TM 60 Alvine Pharmaceuticals 60 Maxy G# 60 Trofex 60 PEGylated anti 60 hematological diseases 60 nanobodies 60 SCIB1 60 glioblastoma multiforme GBM 60 CRTH2 60 defensin mimetic antibiotic 60 systemic juvenile idiopathic 60 FGFR 60 Sciences ABthrax Albuferon 60 lipid nanoparticles 60 vitro assay 60 neuropsychiatric diseases 60 monoclonal antibody mAb 60 Cyclosert TM 60 humanized antibodies 60 JAK3 60 Aeolus Pharmaceuticals 60 mocetinostat MGCD# 60 HyperAcute 60 investigational compounds 60 MVA BN 60 novel therapeutic antibodies 60 subunit vaccine 60 XmAb# 60 cytoprotective 60 including eniluracil ADH 60 FUSILEV ® 60 Tyrosine Kinase Inhibitor 60 BHT DNA 60 mitogen activated ERK kinase 60 hepatitis C viral infection 60 Daclizumab 60 refractory gout 60 delta opioid receptor 60 Amex PTN 60 XmAb 60 Curaxin CBLC# 60 Avian Transgenic Technology 60 Systemic Delivery 60 sunitinib Sutent ® 60 targeting Inflammatory Bowel 60 compound PMX # 60 Thrombin topical Recombinant 60 INOmax R 60 highly selective endothelin 60 M# rationally 60 PI3K/mTOR 60 YM AIM YMBA 60 introduced NEUGENE 60 radiolabeled TM# 60 Chemokine Receptor 60 multitargeted 60 Azedra TM Onalta TM 60 Inhalation Solution 60 AMEX RGN 60 TRO# 60 therapeutic peptide 60 calcineurin inhibitors 60 Chemokine Therapeutics 60 HGS ETR1 60 Lu AA# 60 Lpathomab 60 Adenosine Therapeutics 60 RECOTHROM R 60 hepatitis C HCV 60 modulator SERM 60 oncological indications 60 TM Aganocide 60 nosocomial pneumonia 60 UltiMAb 60 indibulin 60 PET tracers 60 gefitinib Iressa 60 Albugon 60 Zorbtive TM 60 Monoclonal 60 epothilones 60 STEDESA 60 polycythemia vera PV 60 Virulizin ® 60 riociguat 60 Piperacillin 60 RiVax 60 BGC# 60 Gleevec resistant 60 Fleximer 60 asthma COPD Chronic 60 multi kinase inhibitor 60 tkRNAi technology 60 Aplidin 60 molecular chaperone amplification 60 Creabilis Therapeutics 60 Bezielle 60 chemically modified siRNA 60 Inc. OTCBB IRBS 60 R#/MEM # 60 SMaRT ™ 60 AAG geldanamycin analog 60 Pralatrexate 60 non nucleoside HCV 60 validating biomarkers 60 Small Molecule 60 neuraminidase inhibitor 60 AVP #D# 60 Pagoclone 60 Bavituximab 60 StromaCel Inc. 60 fibrotic disease 60 Lisofylline LSF 60 benzimidazole 60 bioactive lipids 60 eTag assays 60 OHR/AVR# 60 BACcel ™ system 60 renin inhibitors 60 Serostim ® 60 hypoxia activated prodrug 60 Tumour Vascular Disrupting Agent 60 Meets Primary Endpoint 60 CINTREDEKIN BESUDOTOX 60 KSP inhibitor 60 Promedior 60 molecular diagnostic assays 60 hyperphenylalaninemia HPA due 60 REP# 60 formerly LymphoStat B 60 including thyroiditis RA 60 lymphoid tumors 60 MGd 60 reformulates existing FDA 60 myeloproliferative neoplasms 60 Cerus Corporation 60 ESBA# 60 Streptococcus pyogenes 60 Kuvan R 60 colorectal bladder 60 Leukine ® 60 sJIA 60 PDE# inhibitors 60 Elagolix 60 Crofelemer budesonide foam 60 Memory MRAM 60 ACTIQ ® 60 XmAb ® 60 Luveris R Ovidrel R 60 Begins Dosing 60 Sym# 60 cause cardiac channelopathies 60 class mGluR5 inhibitor 60 CYP#A# CYP#D# 60 novel RNAi therapeutics 60 peptide fragments 60 antisense compounds 60 Opterone R 60 lomitapide 60 metabonomics 60 TRIOLEX HE# APOPTONE HE# 60 quinolone 60 NASDAQ SNTA biopharmaceutical 60 inhibit metastasis 60 Recombinant Human 60 Monoclonal Antibody 60 selective modulator 60 targeted anticancer biopharmaceuticals 60 vaccine GRNVAC1 60 alvespimycin 60 Vitaxin 60 inhibit KSP 60 OTCBB NVLT biopharmaceutical 60 OPi 60 HCD# [002] 60 Vitamin D analogue 60 selective immunoproteasome inhibitor 60 rhFVIIa 60 Epstein Barr virus EBV 60 GeneICE 60 SERMs 60 Epratuzumab 60 selective androgen receptor modulator 60 Chrysalin 60 orally bioavailable 60 GlycoPEGylated hemostasis compounds 60 BXT # 60 OncoGel 60 cardio renal 60 antitumour 60 CRLX# 60 DP VPA 60 Wafer polifeprosan 60 S1P antibody 60 human metapneumovirus 60 NovaBay Pharmaceuticals 60 stapled peptides 60 Hepatitis C Virus HCV 60 mGluR5 NAM 60 fosbretabulin 60 orally inhaled migraine 60 BACcel 60 pharmacokinetic equivalence 60 PDGF receptor 60 Thiarabine 60 CGEN # 60 delipidation